About PrecisionLife
We're a precision medicine company committed to predicting, treating, and preventing the world's most complex and costly diseases

Our mission
Finding better, more personalized treatment & diagnostic options for people with unmet medical needs
Complex, chronic diseases are difficult to diagnose, expensive to manage, and often lack effective treatments. They represent the biggest challenge to health – affecting billions of patients and accounting for over 80% of global healthcare spending.
We bring the benefits of precision medicine affordably into routine clinical practice and R&D for these most common and costly diseases.
Predicting and preventing chronic diseases to improve patient outcomes and reduce health costs.
This is PrecisionLife.
"To truly understand, predict and prevent complex diseases, we must move beyond symptom-based labels and adopt a fundamentally mechanistic view of biology – just as we did to transform cancer care into precision medicine."
"PrecisionLife leads the world in identifying the mechanisms of disease and turning insights into clinically actionable solutions to reduce the global burden of chronic disease."

Steve Gardner, PhD
CEO & Co-founder, PrecisionLife

A new era of precision medicine
Chronic diseases are caused by a complex interplay of multiple genes and heterogeneous factors. Their complexity means that patients with the same diagnosis may have different drivers of disease and will benefit from different therapies.
These differences cannot be understood by traditional genomic analyses such as GWAS, polygenic risk scores, generative AI, or panel-based diagnostics.
Therefore, while oncology has been transformed by precision medicine, more prevalent and expensive chronic diseases have not.
Until now...
Putting people at the center of their health
We've completely reimagined how to analyze patient data.
Using our Combinatorial Analytics & AI platform we are the first company to understand and stratify complex disease biology – identifying the mechanistic causes of disease in individual patients.
This allows us to create more personalized diagnostic tools, therapy options and clinical pathways, and to find the right patients for new trials and treatments based on their biology.
Increasing success for clinical trials, treatments and patients.
-min%20(1).png)
World-leading science
10x signal from 10% of data
Our platform is world-leading – identifying causal biology, the holy grail of precision medicine, in over 60 complex diseases.
Improving global health
>5 Billion patients lives
Our clinical research studies have created new precision medicine opportunities for diseases that affect 5.4B people.
Proprietary disease insights
>100K protectable IP assets
We've created the most valuable repository of chronic disease insights, including biomarkers, risk models, and novel targets.
Rapid reduction to practice
Reducing the cost of healthcare
Our mechanostic tests identify disease risk for earlier, more personalized intervention and prevention of chronic diseases.